MET and malignant mesothelioma: A significant correlation between MET, ERK5, and the doublecortin-like kinase (DCLK1) expression was found through IHC on TMA of 73 malignant mesotheliomas; higher expression of MET, ERK5, and DCLK1 was detected in 67.1%, 48%, 50.7%, respectively compared to normal pleura showing low or absent reactivity for the three proteins [149].